HRES 477 · 106th Congress · Health

Expressing the sense of the House of Representatives regarding the disparity between identical prescription drugs sold in the United States, Canada, and Mexico.

Introduced 2000-04-13· Sponsored by Rep. Baldacci, John Elias [D-ME-2]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health and Environment.(2000-04-24)

Plain Language Summary

[AI summary unavailable — showing source text] Expresses the sense of the House of Representatives that the cost disparity between identical prescription drugs sold in the United States, Canada, and Mexico should be reduced or eliminated.…

Summarized by Claude AI · Non-partisan · For informational purposes only